Published in J Clin Immunol on November 01, 2001
Marginal zone B-cells, a gatekeeper of innate immunity. Front Immunol (2011) 0.90
Somatic generation of antibody diversity. Nature (1983) 28.06
Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature (1980) 10.19
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell (1989) 9.66
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med (1995) 8.23
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature (1984) 5.75
New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med (1993) 5.32
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature (1981) 4.19
Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol (1995) 3.31
Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol (1994) 2.95
Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science (1993) 2.80
Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J (1988) 2.65
The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med (1998) 2.56
Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med (1991) 2.51
Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest (1997) 2.44
Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J Mol Biol (1993) 2.42
Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol (1991) 2.11
Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science (1993) 2.08
Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol (1997) 2.03
B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today (1990) 1.95
Molecular analysis of V(D)J recombination. Annu Rev Genet (1992) 1.92
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding. AIDS Res Hum Retroviruses (1996) 1.87
Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res Hum Retroviruses (1998) 1.86
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66
Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains. AIDS Res Hum Retroviruses (1992) 1.53
Expressed human immunoglobulin kappa genes and their hypermutation. Eur J Immunol (1993) 1.37
Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41. AIDS Res Hum Retroviruses (1998) 1.36
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. J Mol Biol (1997) 1.33
Receptor editing, immune diversification, and self-tolerance. Immunity (1996) 1.31
Human immunoglobulin VH and D segments on chromosomes 15q11.2 and 16p11.2. Hum Mol Genet (1994) 1.29
Novel rearrangements at the immunoglobulin D locus. Inversions and fusions add to IgH somatic diversity. J Exp Med (1989) 1.25
Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Hum Mol Genet (1995) 1.24
Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J Immunol (1998) 1.20
V lambda and J lambda-C lambda gene segments of the human immunoglobulin lambda light chain locus are separated by 14 kb and rearrange by a deletion mechanism. Eur J Immunol (1991) 1.13
Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J (1994) 1.10
The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J Immunol (1997) 1.08
Molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response. Proc Natl Acad Sci U S A (1991) 1.07
Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody specific to HIV-1-gp41. Nucleic Acids Res (1990) 1.06
Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus. J Clin Invest (1996) 1.05
Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J Clin Invest (1992) 1.05
Revenge of the microbes. Superantigens of the T and B cell lineage. Am J Pathol (1994) 1.04
B-cell superantigens: implications for selection of the human antibody repertoire. Immunol Today (1995) 1.03
Human immunoglobulin VH and VK repertoire revealed by in situ hybridization. Mol Immunol (1990) 1.01
Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J Immunol (2000) 0.99
Structural basis of the gp120 superantigen-binding site on human immunoglobulins. J Immunol (1998) 0.95
A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood (1991) 0.95
Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype. Proc Natl Acad Sci U S A (1994) 0.94
Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual. Eur J Immunol (1999) 0.93
Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission. J Clin Invest (1996) 0.93
Analysis of human VH gene repertoire expression in peripheral CD19+ B cells. Immunogenetics (1995) 0.92
Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr (1994) 0.91
Probing VH gene-family utilization in human peripheral B cells by in situ hybridization. J Immunol (1991) 0.91
Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Mol Immunol (1994) 0.89
A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons. J Infect Dis (2000) 0.88
Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation. Mol Immunol (1993) 0.87
The immunoglobulin kappa locus-or-what has been learned from looking closely at one-tenth of a percent of the human genome. Gene (1993) 0.86
Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus. Blood (1998) 0.85
Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol Lett (1996) 0.83
Development of human antibody variable genes in systemic autoimmunity. Immunol Rev (1992) 0.83
Molecular characterization of human Ig heavy chain DIR genes. J Immunol (1994) 0.82
Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J (1998) 0.81
Analysis of direct and inverted DJH rearrangements in a human Ig heavy chain transgenic minilocus. J Immunol (1995) 0.80
Variable region light chain genes encoding human antibodies to HIV-1. Mol Immunol (1995) 0.79
Unravelling antibody genes. Nat Genet (1994) 0.78
Molecular characterization of a human anti-HIV 1 monoclonal antibody revealed a CD26-related motif in CDR2. Immunol Lett (1995) 0.77
The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region. Br J Cancer (1992) 0.77
Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies. AIDS Res Hum Retroviruses (1994) 0.76
A human anti-HIV autoantibody enhances EBV transformation and HIV infection. Clin Immunol (1999) 0.75
The Nobel Lectures in Immunology. Lecture for the Nobel Prize for Physiology or Medicine, 1984. From the structure of antibodies to the diversification of the immune response. Scand J Immunol (1993) 0.75
IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases. Immunology (1984) 1.37
Receptor editing, immune diversification, and self-tolerance. Immunity (1996) 1.31
A rapid ELISA for measurement of antibodies to nucleic acid antigens using UV-treated polystyrene microplates. J Immunol Methods (1986) 1.15
Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J (1994) 1.10
Expression of anti-idiotypic clones against auto-anti-DNA antibodies in normal individuals. Cell Immunol (1983) 1.08
High titres of anti-T antibodies and other haemagglutinins in human malaria. Clin Exp Immunol (1982) 1.02
UV-treated polystyrene microtitre plates for use in an ELISA to measure antibodies against synthetic peptides. J Immunol Methods (1991) 1.01
Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc Natl Acad Sci U S A (1997) 0.99
Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillating levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient. Ann Immunol (Paris) (1983) 0.98
B cell receptor signaling and autoimmunity. FASEB J (2001) 0.97
Structural basis of the gp120 superantigen-binding site on human immunoglobulins. J Immunol (1998) 0.95
Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype. Proc Natl Acad Sci U S A (1994) 0.94
Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis. FASEB J (1999) 0.94
Analysis of human VH gene repertoire expression in peripheral CD19+ B cells. Immunogenetics (1995) 0.92
Anti-DNA autoantibody activity and idiotypic relationships of human monoclonal proteins. Eur J Immunol (1984) 0.88
Idiotype restriction in human autoantibodies to DNA in systemic lupus erythematosus. Immunol Lett (1984) 0.88
Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity (2001) 0.87
Receptor revision and systemic lupus. Scand J Immunol (2002) 0.86
Suppression of murine lupus autoantibodies to DNA by administration of muramyl dipeptide and syngeneic anti-DNA IgG. J Immunol (1985) 0.86
Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B cell IgM, IgD and IgG during HIV infection. Eur J Immunol (1995) 0.85
Clonotypic dominance and variable gene elements of pathogenic anti-DNA autoantibodies from a single patient with lupus. Scand J Immunol (1994) 0.83
Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol Lett (1996) 0.83
Murine lupus anti-DNA antibodies cross-react with the hapten (4-hydroxy-5-iodo-3-nitrophenyl)acetyl, but immunization-induced anti-DNA antibodies do not. Eur J Immunol (1987) 0.82
Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120. Int Immunol (1992) 0.82
Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J (1998) 0.81
A human monoclonal IgG1 with anti-idiotypic activity against anti-human thyroglobulin autoantibody. J Immunol (1984) 0.81
Antibody epitopes probed by immunoselected phage-display library peptides in members of a family with various rheumatic manifestations. Clin Exp Rheumatol (1997) 0.81
High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus. J Autoimmun (1998) 0.80
Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4. Eur J Immunol (1991) 0.80
Selective alterations of the antibody response to HIV-1. Appl Biochem Biotechnol (1998) 0.80
IgG-subclass expression of anti-DNA and anti-ribonucleoprotein autoantibodies in human malaria. Clin Exp Immunol (1986) 0.80
Variable region light chain genes encoding human antibodies to HIV-1. Mol Immunol (1995) 0.79
Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy. Mycopathologia (1984) 0.79
Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases. J Clin Immunol (1984) 0.78
Subversion of B lymphocyte signaling by infectious agents. Genes Immun (2003) 0.78
Unravelling antibody genes. Nat Genet (1994) 0.78
A novel tissue engineering-based assay for immunological infertility. Scand J Immunol (2008) 0.78
Probing the specificity of human myeloma proteins with a random peptide phage library. Scand J Immunol (2003) 0.77
B-lymphocyte selection and autoimmunity. Trends Immunol (2001) 0.77
Cloning of a gene encoding a lupus-associated human autoantibody VK region using the polymerase chain reaction and degenerate primers. Gene (1991) 0.77
DNA methylation: a potential pathway to abnormal autoreactive lupus B cells. Clin Immunol Immunopathol (1996) 0.76
Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient. Immunology (1995) 0.76
Thymine and guanine base specificity of human myeloma proteins with anti-DNA activity. J Clin Invest (1986) 0.75
Analysis of immunoglobulin VH and TCR cbeta polymorphisms in a large family with thyroid autoimmune disorder. Exp Clin Immunogenet (1999) 0.75
Signaling in human lupus T lymphocytes. Lupus (1998) 0.75
Monomorphic organization of human diversity (DH) heavy chain variable genes. Eur J Immunogenet (1992) 0.75
Autologous anti-antiidiotypic clones in human beings. N Engl J Med (1984) 0.75
Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice. Virology (1994) 0.75
[Heterohemagglutinins in human malaria: immunopathologic implications]. Bull Soc Pathol Exot Filiales (1985) 0.75
Silent antibodies. Arch Inst Pasteur Tunis (2005) 0.75
[Interview with Moncef Zouali: What is going to happen tomorrow in the field of lupus anti-DNA antibodies?]. Ann Med Interne (Paris) (1995) 0.75
Delta agent: a unique hepatotropic particle. Biomed Pharmacother (1985) 0.75
[Demonstration of an abnormal increase of anti-T hemagglutinin titers in malaria infected patients]. C R Seances Acad Sci III (1983) 0.75
Idiotypic expression of anti-gp120 antibodies in unrelated human immunodeficiency virus-infected individuals. J Gen Virol (1992) 0.75
Idiotypic interrelationship among human myeloma proteins with distinct antibody-binding specificities. Rev Fr Transfus Immunohematol (1984) 0.75
Frontiers in clinical immunology 2008. Scand J Immunol (2009) 0.75
[Werner's syndrome and endocrine disorders]. Ann Endocrinol (Paris) (2003) 0.75
Genetic control of DNA antibody production: focus on the heavy chain. Lupus (1997) 0.75
Expression of the tyrosine kinase Lyn during B cell receptor engagement and apoptosis. Ann N Y Acad Sci (1997) 0.75
Polymorphism of the human immunoglobulin heavy chain locus in rheumatoid arthritis. Autoimmunity (1997) 0.75